Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences

RTTNews | 288 일 전
Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences

(RTTNews) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical company focused exclusively on Women's Health.

Lupin's U.S. Commercial Women's Health Specialty Business is primarily focused on commercializing SOLOSEC (secnidazole) 2g oral granules.

This FDA-approved single-dose antimicrobial agent provides a complete course of therapy for the treatment of bacterial vaginosis (BV) and trichomoniasis, two common sexual health infections.

read more
Evofem Biosciences Names Albert Altro As Interim CFO

Evofem Biosciences Names Albert Altro As Interim CFO

Evofem Biosciences, Inc. (EVFM) announced Thursday the appointment of Albert Altro as Interim Chief Financial Officer of the Company. He replaces Jay File, who is leaving the Company to explore other opportunities.
RTTNews | 782 일 전
Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved  In Nigeria

Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved In Nigeria

Evofem Biosciences, Inc. (EVFM) announced Thursday that its hormone-free contraceptive vaginal gel Phexxi has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). This is the first regulatory approval outside the U.S.
RTTNews | 936 일 전
Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi

Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi

Evofem Biosciences, Inc. (EVFM) announced Tuesday it has reached an agreement with one of the nation's largest pharmacy benefit managers (PBMs) to ensure most women covered by this plan can fill their Phexxi prescriptions for pregnancy prevention, without restrictions such as prior authorization or step therapy. Phexxi is an on-demand method of birth control used to prevent pregnancy.
RTTNews | 1036 일 전
CAC 40 Pares Early Gains; Schneider Electric Tumbles Over 7%

CAC 40 Pares Early Gains; Schneider Electric Tumbles Over 7%

French stocks are mostly subdued on Tuesday with investors making cautious moves while awaiting some key corporate earnings updates this week. The market climbed higher earlier in the session as reports emerged that the U.S. would move to reduce the impact of duties imposed on foreign parts in domestically manufactured cars.
RTTNews | 6 분 전
DAX Rises Again As Strong Results, Easing Tariff Concerns Lift Sentiment

DAX Rises Again As Strong Results, Easing Tariff Concerns Lift Sentiment

German stocks are up firmly in positive territory on Tuesday with investors reacting to a slew of corporate earnings announcements. Easing concerns about U.S. tariffs, and data showing an improvement in German consumer sentiment contribute as well to the positive sentiment in the market.
RTTNews | 59 분 전
Spain GDP Growth Softens; Inflation Eases

Spain GDP Growth Softens; Inflation Eases

Spain's economic growth slowed marginally in the first quarter and inflation weakened in April on lower gas and electricity prices, official data showed on Tuesday. Gross domestic product expanded 0.6 percent in the first quarter, which was slightly slower than the revised 0.7 percent growth posted a quarter ago, the preliminary data from the statistical office INE showed.
RTTNews | 1 시간 22 분 전